Navigation Links
Vasogen Announces Third Quarter 2007 Results
Date:10/9/2007

ing our ACCLAIM results, the agency strongly

recommended that we conduct a confirmatory trial ("ACCLAIM-II") of

Celacade in NYHA Class II heart failure patients to support a

Pre-market Approval submission for the purpose of achieving

regulatory approval in the United States. The FDA also recommended

that we use a Bayesian approach in the design of the confirmatory

trial. The FDA indicated that they were recommending this approach

specifically because it would allow us to borrow power from the

ACCLAIM trial and also because it has the potential to substantially

reduce the sample size required for a confirmatory study. The planned

trial design for ACCLAIM-II indicates that as few as 300 patients

could provide sufficient data to confirm the finding of the

phase III ACCLAIM trial which demonstrated a 39% reduction

(p=0.0003) in the risk of death or cardiovascular

hospitalizations for patients receiving Celacade in the large

pre-specified subgroup of 689 NYHA class II heart failure patients.

Furthermore, the use of an adaptive clinical trial design also

provides the flexibility to increase the sample size up to

600 patients, should additional data be required. We are preparing to

meet with the FDA again, with the objective of obtaining formal

regulatory agreement with respect to our proposed trial design prior

to the end of the year.

- James B. Young, MD, Chairman, Division of Medicine at the Cleveland

Clinic Foundation and Medical Director, Kaufman Center for Heart

Failure, has agreed to be the Global Principal Investigator and

Chairman of the Steering Committee for the planned ACCLAIM-II study.

Dr. Young, who has played a leading role in numerous multi-center

clinical trials focusing on heart failure and
'/>"/>

SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Fast, semi-automatic creation ... in documents ChemAxon , a ... services for life science research, launches ChemCurator, an ... structures from documents. Markush structures are ... generating and understanding Markush structures is a difficult ...
(Date:9/30/2014)... BALTIMORE and ROCKVILLE, Md., Sept. 30, 2014 /PRNewswire/ ... private-public partnership focusing on commercializing market-relevant biohealth innovations and ... Maryland , announced today that venture capitalist, ... as a strategic advisor. Dr. Fernandez will be a ... Gap Fund, which will provide up to $50 million ...
(Date:9/30/2014)... The custom stainless steel fabrication company ... 2014. The Boston Area Chapter of ISPE (International Society ... event for Wed., Oct. 1 at Gillette Stadium Clubhouse ... largest in ISPE Boston’s long history, with more than ... expected. , HOLLOWAY AMERICA President David Simpson is ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 On September 11, ... James Sherley in anticipation of a session that he will ... Toxicology Summit,” scheduled for February 17-18, 2015 in London. ... Pharma IQ asked Dr. Sherley to respond to several questions ... toxicity, challenges to evaluating stem cell toxicity, and future trends ...
Breaking Biology Technology:ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4
... If the economy isn't coming back, you couldn't tell it ... Mountains of product releases, a near-electric buzz among attendees, and ... technology tradeshow in recent years. In fact, if the length ... is coming back strong. , ,There were other indicators at ...
... these days - from removing tattoos to playing music ... of Wisconsin, lasers have been harnessed to an entirely ... of Wisconsin-Madison mechanical engineering professor and laser expert, along ... to adapt a so-called "cold laser machining" technique, primarily ...
... Pabst Farms , a 1,500-acre master planned community located ... have reached an agreement in which SBC Wisconsin will ... ,As part of the agreement, SBC-Wisconsin will ... technology to the first Pabst Farms residences and deploy ...
Cached Biology Technology:Consumers Lead Tech Market Comeback 2Consumers Lead Tech Market Comeback 3Wisconsin Engineers Devise Cutting-Edge Method to Cut Cheese 2Wisconsin Engineers Devise Cutting-Edge Method to Cut Cheese 3Pabst Farms to Test SBCs Fiber-to-the-Premises Technology 2Pabst Farms to Test SBCs Fiber-to-the-Premises Technology 3
(Date:9/29/2014)... pizza in school? According to a new Food and ... chef-made meals can increase participation in the National School ... consumption of vegetables by 16%! , Chefs Move to ... campaign, pairs chefs with schools in order to provide ... school food service workers. , A CMTS event was ...
(Date:9/29/2014)... DETROIT In order to support the world,s ... chemicals, polymers and more, new and more efficient ... team of researchers, including several from Wayne State ... of a new grant from the National Science ... Guided Design of Multicomponent Materials for Electrocatalytic Cascade ...
(Date:9/29/2014)... $6 million grant for clinical research and education ... safe and effective treatments for cocaine addiction. , ... of Health, National Institute on Drug Abuse, will ... Cocaine Use Disorder to oversee preclinical and early ... forward with more expensive large-scale clinical trials. , ...
Breaking Biology News(10 mins):Chefs move to schools can increase school meal participation and vegetable intake among students 2Wayne State research aims to develop new, more efficient catalytic materials 2New VCU center to target cocaine addiction 2
... up poor increases a person,s likelihood of health problems ... a Cornell University environmental psychologist shows that being raised ... of poverty. The study, "Loosening the Link Between ... Protective Effects of Social Capital" published in the January ...
... Twenty years after biologists attempted to determine the ... oil spill, scientists dealing with the BP disaster find ... data to determine the ecological consequences of human-induced environmental ... in the Feb. 4 issue of the journal ...
... be powerful enough to survive climate change in the ... in the northwestern United States is likely to warm ... greenhouse gases, according to new computer model simulations carried ... The study found that climate change is likely to ...
Cached Biology News:Cornell researchers find a strong community protects adolescents from risky health behavior 2Wolverine population threatened by climate change 2Wolverine population threatened by climate change 3
Anti-DAP-1, Rabbit Monoclonal Immunogen: KLH-conjugated synthetic peptide corresponding to the C-terminal region of human DAP-1. Molecular Weight: 11 kDa Quality Assurance: Routinely eval...
Mouse monoclonal [TONI-1] to Angiotensin II Type 1 Receptor (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 185 SwissProtID: P30556...
1/4" to 1/8" Adapter for Reflectance Probe Holder...
... (GLP-1), C-terminal reactive. Cross-reacts fully with ... reactivity with the unamidated forms GLP-1(7-37) ... such as hGLP-2, glucagon, hGIP and ... is identical in all mammalian species ...
Biology Products: